PerkinElmer is a global, $3.8bn company committed to innovating for a healthier world. We create instruments, tests, software, and services that are used by scientists, researchers and clinicians to develop innovative drug products.
We strategically partner with companies to enable earlier, more accurate insights, supported by deep market knowledge and technical expertise. Our dedicated team of more than 16,000 employees is passionate about helping them create healthier families, improve quality of life, and sustain the wellbeing of people worldwide.
Through our comprehensive portfolio, we serve four market segments: diagnostics, life sciences, food, and applied markets.
Towards Drug Discovery – Imaging and data visualisation solutions for life science
PerkinElmer supports companies in their efforts to drive a better understanding of the mechanisms behind illnesses such as Covid-19, cancer, Alzheimer’s disease, and heart disease by providing powerful imaging and detection solutions.
Our products can expedite new and improved drug discovery by helping scientists make more informed decisions earlier in the process, as well as by automating research and data integration from genes to cells.
We also aim to help streamline drug development by turning data into actionable insights, increasing productivity on the way to commercialisation, and ensuring all compliance and validation needs are met.
Technologies for the development of novel therapeutics
PerkinElmer technologies have contributed to the development of 22 novel therapeutics to date.
The discovery and development of small-molecule drugs is a long, complex, often iterative, and expensive journey. Each step of the process, from early discovery to manufacturing and delivery, must be fully explored, characterised and understood. Speed to market, declines in productivity, and low success rates present major industry challenges to drug discovery.
PerkinElmer’s best-in-class scientific product portfolio and solutions offering, combined with our world-class expertise in the development of innovative technologies, enables researchers to expedite drug discovery, validate their scientific hypotheses, and overcome the challenges of the pharmaceutical development workflow.
Quality assurance and control processes for pharma
When it comes to QA/QC, PerkinElmer aims to provide clients with everything they need to remain compliant with regulatory requirements, from our analytical instrumentation to our unique OneSource service and support.
When these tools are used together, they work as a system to create safe, high-quality products consumers can trust, along with quality assurance for pharma manufacturers.
Good manufacturing practice (GMP) not only drives the QA/QC inside your company, but also guides PerkinElmer’s development of the technologies, tools, and control processes to assure you are meeting your regulatory obligations and manufacturing compliant products.
From raw material analysis in the receival warehouse, excipient distribution studies in blending, and contamination analysis including elemental impurities, solvent residues, extractables and leachables to final QA and QC procedures, PerkinElmer offers life science solutions that provide fast, accurate and robust data for the highly regulated pharma environment, allowing you to deliver safe and effective novel therapeutics for a healthier world.
Comprehensive disease testing and diagnostic solutions
PerkinElmer aims to expedite the detection of rare diseases, autoimmune disorders, allergies, and infectious diseases such as Covid-19, Lyme disease, and tuberculosis.
We offer solutions for testing expectant mothers for pregnancy-related health risks and foetal abnormalities, as well as screening newborn babies for genetic mutations that are associated with life-threatening disorders.
Solutions for substance analysis in applied markets
PerkinElmer also provides analytical testing solutions for the environment. From detection of dangerous pollutants and contaminants in drinking water and airborne particles to quantifying concentrations of heavy metals and other toxic elements in our soil and water.
Importantly, we also offer technologies for the detection, impact, and regulation of contaminants of emerging concern such as microplastics, perfluoroalkyl and polyfluoroalkyl substances (PFAS), and polypropylene copolymers (PPCPs).
Our innovative integrated products and services provide a full range of market solutions, including chemical and material testing in the Industrial market with our comprehensive portfolio of industrial analytical solutions such as solar energy and electric vehicles, semiconductors, biofuels, petrochemicals, and polymers, as well as aid with recycling analysis for plastics and electronic waste.
Food safety and quality assurance solutions
PerkinElmer provides solutions from detecting harmful levels of toxins, heavy metals and pesticides, to ensuring accurate labelling and compliance with regulations around the globe, they rely on our solutions. We also provide reliable analysis solutions for evaluating the quality of raw materials prior to food processing as well as measuring for targeted nutritional content, maintaining standards for flavour and aroma, sustaining consistency, and to understand how packaging effects food.
Our capabilities include identifying mycotoxins in grains and feeds to help meet regulations and protect consumers, as well as analysing cannabis and hemp for pesticide levels, harmful residues, impurities, and potency levels to provide truth in labelling.